Skip to content

Biomechanical Mechanism of Angled Manual Traction in the Treatment of Mild to Moderate Cervical Spondylotic Myelopathy Based on Jin-Gu Syndrome Differentiation in Traditional Chinese Orthopedics and Traumatology: A Single-Arm Study on "Sui-Shang" Syndrome Type

Biomechanical Mechanism of Angled Manual Traction in the Treatment of Mild to Moderate Cervical Spondylotic Myelopathy Based on Jin-Gu Syndrome Differentiation in Traditional Chinese Orthopedics and Traumatology: A Single-Arm Study on "Sui-Shang" Syndrome Type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000366
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-02
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to Moderate Cervical Spondylotic Myelopathy(CSM)

Interventions

the intervention group:Angled Manual Traction + Standard Care (Cervical Flexion Immobilization + Neurotrophic Therapy): Angled Manual Traction encompasses muscle manipulation, traction techniques, and

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the criteria set forth in the "Expert Consensus on Integrated Western and Chinese Medicine Diagnosis and Treatment of Cervical Spondylosis" with an mJOA score between 12 and 17 (indicating mild to moderate severity); (2) Be between 30 and 75 years of age; (3) Informed and voluntary informed consent. Candidates who meet all three criteria simultaneously are eligible for inclusion.

Exclusion criteria

Exclusion criteria: Participation is disallowed for individuals meeting any of the following criteria: (1) Presence of additional spinal cord injurious conditions (e.g. amyotrophic lateral sclerosis spinal tumors acute spinal cord injuries secondary adhesive arachnoiditis multiple peripheral neuritides etc.) as well as craniocerebral-related central nervous system diseases (e.g. craniocerebral tumors cerebrovascular diseases etc.) and multiple peripheral neuropathy which may lead to cervical and spinal cord damage including limb movement issues sensory and reflex disorders and other related symptoms; (2) Individuals with cervical spine instability or MRI results indicating severe spinal cord compression significant spinal cord edema or degeneration or those who have previously undergone or are scheduled for cervical spine surgery during the trial; (3) Individuals with severe cardiovascular cerebrovascular respiratory or other systemic diseases including oncological and hematological conditions; (4) Patients who have temporomandibular arthritis mandibular tumors thyroid tumors etc who cannot adequately cooperate with treatment; (5) Persons in poor overall health who cannot manage daily self-care; (6) Pregnant women those planning to become pregnant or breastfeeding mothers; (7) Individuals with disabilities (including but not limited to blindness deafness mutism or mental retardation) that hinder their ability to participate in the clinical trial; (8) Any individuals deemed unsuitable for study participation by the investigator.

Design outcomes

Primary

MeasureTime frame
Modified Japanese Orthopaedic Association cervical spine score (mJOA);

Secondary

MeasureTime frame
Gait assessment based on Plantar Pressure Measurement System;limb muscle strength;Assessment of the quality of limb muscles;

Countries

China

Contacts

Public ContactYongjin Li

Guangdong Provincial Hospital of Chinese Medicine

lyj2106@126.com+86 13560357841

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026